195 related articles for article (PubMed ID: 33171752)
1. A Case of Lung Abscess Caused by Double Immunosuppressive Therapy to Treat Ulcerative Colitis.
Tominaga K; Kanazawa M; Tanaka T; Kojimahara S; Sugaya T; Watanabe S; Yamamiya A; Majima Y; Iijima M; Goda K; Irisawa A
Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33171752
[TBL] [Abstract][Full Text] [Related]
2. Multiple esophageal ulcers due to tofacitinib 10 mg twice daily for ulcerative colitis.
Tominaga K; Kanazawa M; Takenaka K; Tanaka T; Sugaya T; Fukushi K; Takagi Y; Nagashima K; Abe K; Izawa N; Tsuchida K; Iijima M; Goda K; Yamagishi H; Irisawa A
Clin J Gastroenterol; 2020 Jun; 13(3):340-343. PubMed ID: 31705375
[TBL] [Abstract][Full Text] [Related]
3. Effect of extended MMX mesalamine therapy for acute, mild-to-moderate ulcerative colitis.
Kamm MA; Lichtenstein GR; Sandborn WJ; Schreiber S; Lees K; Barrett K; Joseph R
Inflamm Bowel Dis; 2009 Jan; 15(1):1-8. PubMed ID: 18671232
[TBL] [Abstract][Full Text] [Related]
4. A Case of Stevens-Johnson Syndrome Complicated with Multimatrix System Mesalamine in Ulcerative Colitis.
Kanazawa M; Tominaga K; Kanamori A; Tanaka T; Masuyama S; Watanabe S; Abe K; Yamamiya A; Goda K; Irisawa A
Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208599
[TBL] [Abstract][Full Text] [Related]
5. Once-daily MMX(®) mesalamine for endoscopic maintenance of remission of ulcerative colitis.
D'Haens G; Sandborn WJ; Barrett K; Hodgson I; Streck P
Am J Gastroenterol; 2012 Jul; 107(7):1064-77. PubMed ID: 22565161
[TBL] [Abstract][Full Text] [Related]
6. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis.
Ardizzone S; Maconi G; Russo A; Imbesi V; Colombo E; Bianchi Porro G
Gut; 2006 Jan; 55(1):47-53. PubMed ID: 15972298
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
Cohen RD; Woseth DM; Thisted RA; Hanauer SB
Am J Gastroenterol; 2000 May; 95(5):1263-76. PubMed ID: 10811338
[TBL] [Abstract][Full Text] [Related]
8. Mesalamine with MMX technology for the treatment of ulcerative colitis.
Schreiber S; Kamm MA; Lichtenstein GR
Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):299-314. PubMed ID: 19072380
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety and tolerability of once-daily mesalamine granules in the maintenance of remission of ulcerative colitis.
Lichtenstein GR; Barrett AC; Bortey E; Paterson C; Forbes WP
Inflamm Bowel Dis; 2014 Aug; 20(8):1399-406. PubMed ID: 24874460
[TBL] [Abstract][Full Text] [Related]
10. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.
Rembacken BJ; Snelling AM; Hawkey PM; Chalmers DM; Axon AT
Lancet; 1999 Aug; 354(9179):635-9. PubMed ID: 10466665
[TBL] [Abstract][Full Text] [Related]
11. Ulcerative colitis occurring in the course of rheumatoid arthritis: a case successfully treated with mesalamine enema.
Sugisaki K; Honma F; Iwadate H; Shio K; Shioya Y; Fukaya E; Sato K; Saito H; Sekine H; Kobayashi H; Orikasa H; Watanabe H; Sato Y
Intern Med; 2004 Nov; 43(11):1046-50. PubMed ID: 15609700
[TBL] [Abstract][Full Text] [Related]
12. Use of Curcumin in Achieving Clinical and Endoscopic Remission in Ulcerative Colitis: A Systematic Review and Meta-analysis.
Iqbal U; Anwar H; Quadri AA
Am J Med Sci; 2018 Oct; 356(4):350-356. PubMed ID: 30360803
[TBL] [Abstract][Full Text] [Related]
13. Comparison of QD and TID oral mesalazine for maintenance of remission in quiescent ulcerative colitis: a double-blind, double-dummy, randomized multicenter study.
Watanabe M; Hanai H; Nishino H; Yokoyama T; Terada T; Suzuki Y
Inflamm Bowel Dis; 2013 Jul; 19(8):1681-90. PubMed ID: 23624890
[TBL] [Abstract][Full Text] [Related]
14. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
15. Ulcerative Colitis.
Sonnenberg E; Siegmund B
Digestion; 2016; 94(4):181-185. PubMed ID: 27931025
[TBL] [Abstract][Full Text] [Related]
16. A practical guide to the management of distal ulcerative colitis.
Ardizzone S; Bianchi Porro G
Drugs; 1998 Apr; 55(4):519-42. PubMed ID: 9561342
[TBL] [Abstract][Full Text] [Related]
17. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU).
Fernández-Bañares F; Hinojosa J; Sánchez-Lombraña JL; Navarro E; Martínez-Salmerón JF; García-Pugés A; González-Huix F; Riera J; González-Lara V; Domínguez-Abascal F; Giné JJ; Moles J; Gomollón F; Gassull MA
Am J Gastroenterol; 1999 Feb; 94(2):427-33. PubMed ID: 10022641
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of sodium hyaluronate (IBD98E) in the induction of clinical and endoscopic remission in subjects with distal ulcerative colitis.
Fiorino G; Gilardi D; Naccarato P; Sociale OR; Danese S
Dig Liver Dis; 2014 Apr; 46(4):330-4. PubMed ID: 24462118
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis.
Sinha A; Nightingale J; West KP; Berlanga-Acosta J; Playford RJ
N Engl J Med; 2003 Jul; 349(4):350-7. PubMed ID: 12878742
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group.
Miner P; Hanauer S; Robinson M; Schwartz J; Arora S
Dig Dis Sci; 1995 Feb; 40(2):296-304. PubMed ID: 7851193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
